| Nucleoside transport inhibition and platelet aggregation in human blood: R75231 and its enantiomers, draflazine and R88016. | |
| | |
MedLine Citation:
|
PMID: 8137884 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In this study, we determined whether R75231, (+/-)-2-(aminocarbonyl)-N-(4-amino-2,6-dichlorophenyl)-4-[5,5-bis( 4-fluoro- phenyl)pentyl]-1-piperazineacetamide, and its two enantiomers, all nucleoside transport inhibitors, could play a role as anti-aggregatory agents. First, we determined the binding characteristics of [3H]nitrobenzylthioinosine, also a nucleoside transport inhibitor, on intact human erythrocytes. The Kd value was 0.27 +/- 0.04 nM and the Bmax was 23.5 +/- 5.1 pmol/10(9) erythrocytes. Second, we studied the ability of R75231 and its enantiomers R88021 ((-)-R75231, or draflazine) and R88016 ((+)-R75231), to displace [3H]nitrobenzylthioinosine. R75231 had an IC50 value of 2.2 +/- 0.3 nM. R88021 was twice as potent as R75231 and R88016 was approximately 20-fold less potent than R75231. Finally, the ability of these nucleoside transport inhibitors to enhance anti-aggregatory effects of adenosine was examined in whole human blood. Adenosine alone, 10 microM, had no effect on ADP-induced platelet aggregation. However, in the presence of 1 microM R75231, 10 microM of adenosine inhibited the aggregatory response completely. Dose-response curves indicated that the IC50 values of draflazine and R88016 were approximately 0.5 microM and 10 microM, respectively. R75231 and its enantiomers are valuable research tools to assess the role of the nucleoside transporter. Moreover, R75231 and draflazine (R88021) may prove to be useful as anti-aggregatory agents. |
| | |
Authors:
|
M W Beukers; C J Kerkhof; A P IJzerman; W Soudijn |
Related Documents
:
|
8252674 - Effects of adenosine on rate-dependent atrioventricular nodal function. potential roles... 1599494 - A novel route of atp synthesis. 1967114 - Response of liver to glucocorticoid is altered by administration of shosaikoto (kampo m... 162434 - Correlated effects of cigarette smoke components on alveolar macrophage adenosine triph... 7703484 - Inherited thrombocytopenia caused by reduced platelet production in mice with the gunme... 1321354 - Interleukin-1-beta induces pituitary adrenocorticotropin secretion: evidence for glucoc... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: European journal of pharmacology Volume: 266 ISSN: 0014-2999 ISO Abbreviation: Eur. J. Pharmacol. Publication Date: 1994 Jan |
Date Detail:
|
Created Date: 1994-04-25 Completed Date: 1994-04-25 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 1254354 Medline TA: Eur J Pharmacol Country: NETHERLANDS |
Other Details:
|
Languages: eng Pagination: 57-62 Citation Subset: IM |
Affiliation:
|
Division of Medicinal Chemistry, Leiden-Amsterdam Center for Drug Research, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenosine
/
pharmacology Adenosine Diphosphate / pharmacology Binding Sites Biological Transport / drug effects Blood Platelets / drug effects Erythrocytes / drug effects*, metabolism Humans Piperazines / pharmacology* Platelet Aggregation / drug effects* Platelet Aggregation Inhibitors / pharmacology* Radioligand Assay Stereoisomerism Thioinosine / analogs & derivatives*, blood |
| Chemical | |
Reg. No./Substance:
|
0/Piperazines; 0/Platelet Aggregation Inhibitors; 120770-34-5/draflazine; 38048-32-7/4-nitrobenzylthioinosine; 574-25-4/Thioinosine; 58-61-7/Adenosine; 58-64-0/Adenosine Diphosphate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Localization of [125I]SAP-N3 binding in the human platelet thromboxane A2/prostaglandin H2 receptor ...
Next Document: NMDA receptor-mediated stimulation of rat cerebellar nitric oxide formation is modulated by cyclic A...